• M Barbero-Mielgo, J García-Fernández, B Alonso-Menarguez, B San Antonio-San Román, V Molnar, and F Gilsanz-Rodríguez.
• Servicio de Anestesiología, Reanimación y Terapéutica del dolor, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, España. Electronic address: mak_barbero@hotmail.com.
• J Healthc Qual Res. 2020 Mar 1; 35 (2): 65-72.

Background And ObjectiveA good acute pain control is necessary to achieve the main objective of Enhanced recovery After Surgery (ERAS) programs and accelerate recovery. The study objective is to evaluate postoperative (PO) acute pain, PO opioid consumption, and its association with functional recovery, after implementing a colorectal surgery ERAS program. An analysis was made as regards drugs adverse effects.MethodsObservational cohort study on scheduled colorectal Surgery: one prospective cohort subjected to the ERAS care program, and one retrospective cohort that received traditional non-standardised care. A record was made of mean pain intensity (measured by a visual analogue scale, which classifies pain intensity from 0 to 10, from lower to higher intensity), as well as the amount of opioid consumption on the day of surgery and on the first three postoperative days, and drugs adverse effects. An analysis was made of the association between PO opioid consumption and ERAS program, and between PO opioid consumption and functional recovery.ResultsThe study included a total of 410 patients (313 in the ERAS group and 97 in the control group). In the ERAS group, it was observed that the mean visual analogue scale was less than 2, with a smaller amount of PO opioid consumption, on each single day and the accumulated amount of the four days (4 [0-24] vs. 0 [0-4], P<.001). PO opioid consumption was associated with functional recovery (OR 0.97 [95% CI; 0.96-0.99], P=.011). No drugs adverse effects were observed.ConclusionsAfter implementing a colorectal Surgery ERAS program, good pain control was achieved, as well as a reduction in PO opioid consumption, which is associated with functional recovery. No drugs adverse effects were observed.Publicado por Elsevier España, S.L.U.

10 keywords...

hide…